Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droxidopa in Hypotensive Patients with Unique Autonomic Symptoms
NCT00581477Phase 3Terminated
- Sponsor
- Vanderbilt University
- Start
- Jan 2004
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of droxidopa in orthostatic hypotension (OH), sponsored by Vanderbilt University. Primary endpoint: Change in Systolic Blood Pressure With Standing. Started Jan 2004; status: terminated.
02
Drugs
droxidopa
03
Conditions
orthostatic hypotension (OH)
Beyond the preview
Go deeper on NCT00581477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00581477.